U.S. markets close in 1 hour 54 minutes

  • S&P 500

    4,089.77
    -38.06 (-0.92%)
     

  • Dow 30

    33,715.17
    -345.49 (-1.01%)
     

  • Nasdaq

    13,190.45
    -113.19 (-0.85%)
     

  • Russell 2000

    2,181.65
    -29.23 (-1.32%)
     

  • Crude Oil

    63.48
    -2.01 (-3.07%)
     

  • Gold

    1,881.40
    +13.40 (+0.72%)
     

  • Silver

    27.97
    -0.37 (-1.30%)
     

  • EUR/USD

    1.2192
    -0.0034 (-0.28%)
     

  • 10-Yr Bond

    1.6570
    +0.0150 (+0.91%)
     

  • GBP/USD

    1.4138
    -0.0049 (-0.35%)
     

  • USD/JPY

    109.1140
    +0.2240 (+0.21%)
     

  • BTC-USD

    39,050.99
    -3,969.73 (-9.23%)
     

  • CMC Crypto 200

    1,024.78
    -92.69 (-8.29%)
     

  • FTSE 100

    6,950.20
    -84.04 (-1.19%)
     

  • Nikkei 225

    28,044.45
    -362.39 (-1.28%)
     

SHAREHOLDER ALERT: DDD CAN EBS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 19, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

3D Systems Corporation (NYSE:DDD)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/3d-systems-corp-loss-submission-form?prid=15938&wire=1
Lead Plaintiff Deadline: June 8, 2021
Class Period: May 6, 2020 - March 1, 2021

Allegations against DDD include that: (1) 3D Systems lacked proper internal controls over financial reporting; and (2) as a result, 3D Systems' public statements were materially false and/or misleading at all relevant times.

Canaan Inc. (NASDAQ:CAN)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/canaan-inc-loss-submission-form-2?prid=15938&wire=1
Lead Plaintiff Deadline: June 14, 2021
Class Period: February 10, 2021 - April 9, 2021

Allegations against CAN include that: they concealed that due to ongoing supply chain disruptions and the introduction of the Company's next-generation A12 series bitcoin mining machines - which had cannibalized sales of the older product offerings - Canaan's 4Q20 sales had declined more than 93% year-over-year compared to its fourth quarter fiscal year 2019 ("4Q19") sales and more than 93% quarter-over-quarter compared to its third quarter FY20 ("3Q20") sales.

Emergent Biosolutions Inc. (NYSE:EBS)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/emergent-biosolutions-inc-loss-submission-form?prid=15938&wire=1
Lead Plaintiff Deadline: June 18, 2021
Class Period: July 6, 2020 - March 31, 2021

Allegations against EBS include that: (i) Emergent's Baltimore plant had a history of manufacturing issues increasing the likelihood for massive contaminations; (ii) these longstanding contamination risks and quality control issues at Emergent's facility led to a string of FDA citations; (iii) the Company previously had to discard the equivalent of millions of doses of COVID-19 vaccines after workers at the Baltimore plant deviated from manufacturing standards; and (iv) as a result of the foregoing, Defendants' public statements about Emergent's ability and capacity to mass manufacture multiple COVID-19 vaccines at its Baltimore manufacturing site were materially false and/or misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/648232/SHAREHOLDER-ALERT-DDD-CAN-EBS-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines

Recommended Stories

  • Ark Investment’s Cathie Wood Says Bitcoin Will Go to $500,000

    Wood made the prediction even as the leading cryptocurrency tumbled on Wednesday.

  • JPMorgan hires UBS banker Novak for activism defense team

    JPMorgan Chase has hired veteran banker Darren Novak from UBS to lead its shareholder activism defense efforts in Europe, the Middle East and Africa, three people familiar with the matter said. JPMorgan declined to comment and Novak did not respond to a request for comment. Novak joined UBS in 2017 and moved to the London office from New York in 2019.

  • China Will Need to Give Up FX Controls Eventually, PBOC Official Says

    (Bloomberg) -- Sign up for the New Economy Daily newsletter, follow us @economics and subscribe to our podcast.China has to give up its control over the currency’s exchange rate eventually if it wants to achieve greater global use of the yuan, according to a central bank official.The yuan exchange rate will have to be determined by global market participants, and this will allow China to have free cross-border capital flows and pursue an independent monetary policy, Zhou Chengjun, director of the People’s Bank of China’s finance research institute, said in a speech published Wednesday.“We need to admit that under the condition of yuan internationalization, we won’t be able to control the exchange rate, and China’s central bank has to let go of exchange-rate goals in the end,” said Zhou. He made the comments at a forum on April 16, according to a transcript released by the forum organizer.The PBOC has made it clear it has stopped regular intervention and will let the market play a bigger role in deciding the exchange rate, Zhou said. He cited the fact the yuan has weakened past 7 per U.S. dollar -- previously seen as an important psychological threshold -- in the past two years, and said it’s one of the more volatile major currencies in the world.The yuan will appreciate against the U.S. dollar in the long term as a result of China’s continued economic growth and the rising purchasing power of the currency, as well as the Federal Reserve’s repeated monetary easing, according to the speech. The onshore yuan advanced to its strongest level since 2018 last week, even though the PBOC tried to moderate the gains by setting the daily fix at a weaker-than-expected level.The U.S. has abused its power to carry out sanctions through the dollar’s dominance in global payments and settlements, and more countries and market entities are hoping to reduce their reliance on the dollar, Zhou said. This provides a great opportunity for China to promote wider use of the yuan, he said.More stories like this are available on bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Santander's Botin defends Orcel offer as CEO row reaches court

    MADRID (Reuters) -Santander boss Ana Botin defended the bank's actions in a court hearing over the withdrawal of a multi-million euro offer more than two years ago to make Italian banker Andrea Orcel its CEO. It ended up in a Madrid court after Spain's largest lender dropped plans to make Orcel, previously the top investment banker at Swiss bank UBS, chief executive as a result of a dispute over his pay package. Orcel and Botin, both wearing dark suits and masks, sat in the front row at the hearing, which was held in a conference hall instead of a traditional court due to COVID-19 protocols and because of the intense media interest in the case.

  • Cathie Wood, Still a Bitcoin Believer, Sees It Going to $500,000

    (Bloomberg) -- Cathie Wood is keeping the faith, even in the face of Bitcoin’s massive plunge that had wiped $500 billion from the coin’s peak market value at one point.The head of Ark Investment Management said in an interview on Bloomberg TV that she still expects the cryptocurrency to reach a price of $500,000. She noted that as highly volatile sectors in the stock market are selling off amid inflation fears, Bitcoin is dropping as well. It last traded just below $38,000.“We go through soul searching times like this and scrape the models, and yes our conviction is just as high,” she said.Although Elon Musk has soured on Bitcoin due to its environmental impact, Wood said once renewables are incorporated into the Bitcoin mining technology, like she expects, “Elon will come back and be part of that ecosystem.”Musk’s quick change in opinion on the largest cryptocurrency may have been caused by pushback from institutional shareholders like BlackRock, she said.Despite her long-term conviction, Bitcoin and other digital coins may face more pain before mounting a comeback.“You never know how low is low when a market gets very emotional,” she said. “I think we’re in a capitulation phase. That’s a really great time to buy no matter what the asset is.”Wood has consistently loaded up on shares of Coinbase Global Inc. in the past two weeks as the cryptocurrency exchange has dipped below its April direct listing reference price and to a record low on Wednesday.In the interview, Wood also addressed the prospects for a Bitcoin exchange-traded fund to be approved in the U.S. this year, which appears to some less likely after a string of comments from regulators. Wood thinks the latest plunge could be a good thing for the prospects of approval. “The odds are going up now that we have had this correction,” she said.Although her funds have taken a hit this year, with her flagship Ark Innovation ETF down more than 34% from its high in February, the firm’s product line-up hasn’t yet faced a monthly outflow, she said.“There were a lot of commentators out there, shall I say, screaming about how our ETFs would have to shut down, which is impossible,” she said.In fact, the move toward value sectors that’s caused her funds to suffer is encouraging to her.“The forces that the coronavirus put in motion supporting all of the innovation in which we invest, they’re not looking back,” she said. “We’re looking at this saying: Alright, on sale. Innovation is on sale. Oh and by the way, the bull market had broadened out.”More stories like this are available on bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Walmart Shares Climb on Q1 Earnings Beat and Raised Outlook; Target Price $180 in Best Case

    Walmart shares rose as much as 4% on Tuesday after the Bentonville, Arkansas-based retailer reported better-than-expected earnings and revenue in the first quarter and lifted its full-year guidance.

  • Bitcoin Proxy Stocks Tumble as BTC Tanks

    Crash in the leading cryptocurrency hitting related companies.

  • Explainer: What Beijing's new crackdown means for crypto in China

    Chinese regulators have tightened restrictions that ban financial institutions and payment companies from providing services related to cryptocurrencies, marking a fresh crackdown on digital money. Compared with a previous ban issued in 2017, the new rules greatly expanded the scope of prohibited services, and judged that "virtual currencies are not supported by any real value". Three financial industry associations on Tuesday directed their members, which include banks and online payment firms, not to offer any crypto-related services, such as account openings, registration, trading, clearing, settlement and insurance, reiterating the 2017 ban.

  • Epic Tries to Show Apple Is Antitrust Violator Beyond App Store

    (Bloomberg) -- A top Apple Inc. executive tasked with defending the App Store in a monopoly lawsuit by Epic Games Inc. found himself having to answer Tuesday for a spate of other alleged antitrust fouls by the world’s most valuable company.During Phil Schiller’s cross-examination in a trial in Oakland, California, Apple’s former global marketing chief was confronted about several instances in which the company has locked in users and made it difficult for them to switch away from its devices.Katherine Forrest, a lawyer for Epic, pointed out that Schiller emailed his colleagues a 2016 news article titled “iMessage is the glue that keeps me stuck to the iPhone,” which explained that Apple’s messaging platform is a reason people don’t switch to Android devices.She also quizzed Schiller on the idea that users can’t easily move music and video purchased on Apple services to Google’s Android. She went further, indicating that Apple’s iCloud Keychain service for storing passwords on Apple devices can’t synchronize with Android devices. Her point: Apple doesn’t just lock in developers with its App Store rules, it also locks in consumers, limiting their ability to switch to competitors.In response, Schiller said many users subscribe to video and music streaming services and can input their passwords into a new device manually. He also suggested that users could use third-party password managers.Read More: Epic-Apple Trial Hangs Over Some 50,000 Games on App StoreEpic’s lawyer also sought to show U.S. District Judge Yvonne Gonzalez Rogers, who will decide the App Store case without a jury, that Apple has been in antitrust cross-hairs before.In 2012, the U.S. Justice Department brought a price-fixing case against Apple over the cost of eBooks on the iPad and iPhone’s built-in book reading app. Apple ended up settling for $450 million, but was required to have a government appointed monitor interview executives and review the company’s policies. Schiller said he wasn’t involved in the case, but Forrest said the monitor tried in vain for a year and a half to get permission to interview Schiller.Another point of contention was Apple’s announcement in November of a new program to reduce App Store fees from 30% to 15% for developers who generate under $1 million per year in revenue. Schiller couched it as an initiative to help small businesses during the Covid-19, but acknowledged under questioning that the company was also pivoting in response to worldwide scrutiny over App Store practices.In an attempt to demonstrate that Apple favors its in own apps in search results on the App Store -- another type of anticompetitive behavior -- Forrest showed an exhibit of Apple Music and Apple News appearing on the top of search result rankings instead of third-party apps.Schiller had an answer for that too: Search algorithms look at dozens of different variables, including which apps users already have on their devices.More stories like this are available on bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Bitcoin, ethereum plunge as sell-off smashes crypto sector

    Bitcoin and ether tumbled on Wednesday to 3-1/2 month lows, on track to post their largest one-day loss since March last year, in the wake of China's move a day ago to ban financial and payment institutions from providing cryptocurrency services. At one point during the meltdown, nearly $1 trillion was wiped off the cryptocurrency's market capitalization. Bitcoin, the biggest and best-known cryptocurrency, had already been under pressure from a series of tweets from Tesla boss Elon Musk, but the news from China sent it further down, It hit a 3-1/2-month low of $30,066.

  • Gold Climbs to Four-Month High as Markets Tumble, Yields Ease

    (Bloomberg) -- Gold advanced to the highest since January as bond yields slipped and equity markets tumbled, boosting demand for the metal as a haven.U.S. stocks fell on concern about faster inflation and Covid-19 flareups in some nations. Technology stocks extended a slide as Bitcoin’s plunge sent cryptocurrency-linked shares lower. Yields on 10-year Treasuries were steady after giving up early gains.Gold has been buoyed by falling real bond yields and a weakening dollar, with inflation expectations in the U.S. rising. That’s revived investor interest in gold, with holdings in bullion-backed exchange-traded funds rebounding. Federal Reserve minutes due later Wednesday may offer more insight into how policy makers view growing price pressures.“It’s flight to safety” that’s helping gold, said Bob Haberkorn, senior market strategist at RJO Futures. “Bitcoin is down - it feels that the safety trade that was in crypto is probably coming to gold this morning. Equities are also down.”Spot gold rose as much as 1.1% to $1,890.13 an ounce, the highest since Jan. 8 before trading at $1,880.10 at 10:43 p.m. in New York. Silver, platinum and palladium fell. The Bloomberg Dollar Spot Index rose after declining 0.3% on Tuesday.Gold’s “technical picture is strong after a correction from overbought conditions, and the market will have noticed that we’ve now had eight days’ consecutive gains in the ETFs, which can help to sway sentiment,” said Rhona O’Connell, an analyst at StoneX Group. Geopolitiical risk, notably in the Middle East, also helps sentiment toward gold as a haven, she said.More stories like this are available on bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Bitcoin Drops to $36K, Triggering $8B in Liquidations

    The price of bitcoin is now down more than 30% so far in May, on track for its worst month since November 2018.

  • ‘Extreme Fear’ Grips Bitcoin Market After Price Plunge, Sentiment Gauge Shows

    The drop in market sentiment follows the past week's bitcoin price plunge, according to Arcane Research.

  • Gamestop, AMC short sellers sit on nearly $1 billion loss - Ortex

    Investors are estimated to have lost $930 million on their short positions in meme stocks GameStop and AMC Entertainment over the last five trading days, data from financial analytics firm Ortex showed on Tuesday. Shares in GameStop, which was at the heart of the so-called "stonks" retail trading mania earlier this year, have risen by a third in the last one week, while shares in cinema operator AMC are up 39%. Ortex said short interest in AMC is currently estimated to be 18.3% of freefloat and in GME it is estimated at 21.8% of freefloat.

  • MGM Gains on JP Morgan Upgrade, Citing Improving Las Vegas Traffic

    By Dhirendra Tripathi

  • Bitcoin Chart Indicator Suggests Worst of Pullback May Be Over

    Experienced hands look to be buying the dip as a key bitcoin price indicator suggests the pullback may be coming to an end.

  • AMC Entertainment Stock Is Soaring Again — and the Meme Trade Won’t Die

    U.S. will share Covid vaccine doses abroad, Amazon mulling acquisition of MGM movie studio, Coinbase is issuing a convertible bond, and other news to start your day.

  • Crypto Lender Mistakenly Deposits Bitcoin Into User Accounts

    (Bloomberg) -- BlockFi Inc., a crypto-lending startup, mistakenly sent some users Bitcoin as part of a promotion and is working on reversing it.The company made what it called incorrect promo payouts in Bitcoin instead of U.S. dollars to certain customers. Though BlockFi worked on reversing them, a number of recipients withdrew the coins before the company could backpedal. (It was fewer than 100, the company said.) The firm’s exposure is around $10 million, though that amount is decreasing as more users return the coins, said Zac Prince, co-founder and chief executive officer of BlockFi.“BlockFi carries loss reserves as part of its accounting policies and this is a fraction of existing loss reserves -- so no negative impact to equity or ongoing platform operations,” Prince wrote by email. “The issue that caused the withdrawals was fixed and incremental safeguards have been developed to prevent any similar issue in the future.”The erroneous deposits have not affected BlockFi’s ongoing operations and the company is notching record levels of trading volume without interruption, he added.Meanwhile, screenshots of the deposits made their rounds on social media, with at least one Tweet showing a deposit of 700 Bitcoin. Though it’s down significantly this week, each coin is trading around $34,000 Wednesday.Last week, BlockFi tweeted that some promotion participants “may see an inaccurate bonus payment displayed in their transaction history.”Meanwhile, the company’s emailed affected users asking for the money to be returned.BlockFi, perhaps the most visible nonbank ­cryptocurrency firm, offers a number of crypto products, including borrowing and lending and it runs platforms for trading cryptocurrency. It’s been in the limelight as it’s grown in recent months amid a crypto-market rally that’s being unwound this week.Read more: Lending Bitcoin to Earn 6% Comes With Risk You Won’t Get at BankThe crypto firm’s snafu is reminiscent of Citigroup Inc.’s $500 million blunder last summer when it accidentally sent payments to a group of lenders.“As a stand-alone, it was just a glitch,” Mike Loukas, chief executive officer at TrueMark Investments, said of BlockFi. “We see it with banks all the time in dollars. But because it’s such a volatile asset, the mistake gets magnified.”More stories like this are available on bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • A SPAC Will Buy Back Its Own SPAC and Pay a Staggering Premium

    (Bloomberg) -- It’s the latest twist in the world of blank-check mergers: A company plans to go public with a SPAC and use it to buy back an affiliate that it took public using another SPAC.This circular scenario revolves around a drugmaker called Roivant Sciences Ltd., which wants to merge with a special-purpose acquisition company and then take over a SPAC that acquired Immunovant Inc. from Roivant less than two years ago.What’s more, Roivant says it knows something that everyone else doesn’t about its former unit, and it’s willing to pay a premium for the shares -- perhaps as much as 70% by one estimate.A SPAC-on-SPAC deal is such an oddity that people who follow shell companies can’t remember it happening before, or anything like Roivant’s head-spinning version. “In the years I’ve been analyzing SPACs, I’ve never seen a transaction like this,” said Neil Danics, founder of SPAC Analytics in Toronto and who has been providing research on the industry since 2007. Roivant outlined the machinations in regulatory filings amid wobbling enthusiasm for SPACs, which collectively have lost about a quarter of their value since their February peak amid tighter scrutiny from regulators. They’re called blank-check companies because they raise money from investors with the goal of buying an existing private business, typically without identifying a target.In this case, Roivant already said in a March filing it wants to re-acquire Immunovant, which is testing a treatment for autoimmune diseases. There’s a whiff of hidden value, because Roivant specifically said it’s willing to pay more than the current price, a premium that Robert W. Baird & Co. estimates could amount to $1.1 billion. Immunovant now trades around $15 a share with a market value of about $1.5 billion.“If you can raise a bunch of money with a SPAC and then use that relatively cheap cash to buy a company at a valuation they find attractive -- that seems like a rational approach,” says Nikolai Roussanov, a finance professor at the University of Pennsylvania’s Wharton School.The plan goes like this: Roivant has proposed to be acquired by a SPAC called Montes Archimedes Acquisition Corp. in a combination valued at about $7.3 billion, according to filings. Roivant would be the surviving entity, and in turn, would offer a mix of stock and cash to buy up shares that it doesn’t already own in Immunovant, an early-stage drugmaker. Roivant spun that off in 2019 into a SPAC called Health Sciences Acquisitions Corp., in return for shares and other considerations initially valued at $395 million.Monoclonal AntibodiesThe reason Roivant is willing to pay up isn’t immediately clear. Human trials on Immunovant’s main prospect, a monoclonal antibody injection aimed at ailments such as myasthenia gravis and thyroid eye disease, were halted February 2 because of concern about potential side effects.Managers at Roivant are pushing ahead anyway, saying that as the parent company with a 57.5% stake, they’ve received “non-public” information about Immunovant. Roivant representatives declined to comment on the transaction. Completion of Roivant’s deal with Montes is expected in the third quarter, and more data about Immunovant’s drug may come out by then.“The market would be happy with a premium transaction,” Baird’s Brian Skorney said about Immunovant, whose shares trade about 11% higher than when it merged with Health Sciences. “There’s been some ambiguity -- concerns about safety problems that cut the stock in half from highs. Maybe Roivant knows it’s a moderate issue.”Roivant itself shows a paper gain of about 117% on Immunovant, with more than half coming from “earnouts” that granted Roivant more shares when milestones were met. They were worth a lot more back in February, before Immunovant plunged from more than $43 after pausing a trial of its IMVT-1401 for thyroid eye disease, citing elevated total cholesterol and low-density lipoprotein or LDL.SPACs, SpinoffsRoivant is no stranger to drug development. Led by charismatic co-founder Vivek Ramaswamy since 2014, it houses several early-stage biopharmaceutical units, and has spun out several companies using traditional IPOs and SPACs.The company historically operated as an in-licensing drug developer, buying rights for other companies’ drugs to further develop them. At last count, its 800 employees worked on more than 40 potential medicines with two approvals from the Food and Drug Administration. Ramaswamy stepped down as chief executive in January to become executive chairman, with finance chief Matthew Gline taking his place.“I want Roivant to be seen as a next-gen pharma company,” Gline said in an interview. He pointed to recent investments in computational tools for drug discovery as well as drug development, including Roivant’s acquisition of Silicon Therapeutics.Some holders didn’t wait to see how it all turns out. Adage Capital Partners sold its entire stake in Immunovant during the first quarter. RTW Investments LP -- which is providing bridge financing for Roivant’s SPAC deal with Montes -- cut its holdings by 16% to 6.36 million shares, leaving it with a 6.5% stake. Representatives for Adage and RTW didn’t respond to messages.More stories like this are available on bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Big money investors suggest the cycle has peaked: Morning Brief

    Top news and what to watch in the markets on Wednesday, May 19, 2021.